Funding, News and Announcements
» Go to news mainHIV and HTLV 1 Biosafety Directive
The Public Health Agency of Canada (PHAC) has recently conducted risk assessments on HIV and HTLV-1 in collaboration with an Ad hoc group of HIV and HTLV-1 experts. These risk assessments determined that HIV and HTLV-1 remain Risk Group 3 (RG3) human pathogens; however, the containment requirements for working with these viruses could be reduced from Containment Level 3 (CL3) to CL2, with the use of additional operational practices, while maintaining the same level of safety. To address this change in containment requirements, PHAC has developed a Biosafety Directive for Human Immunodeficiency Virus (HIV) and Human T-cell Lymphotropic Virus Type 1 (HTLV-1) which provides a comprehensive overview of the updated containment level requirements for laboratories working with HIV and HTLV-1. It is important to note that the Biosafety Directive for HIV and HTLV-1 is to be utilized in conjunction with the (CBSG) 1st edition.
The Biosafety Directive for HIV and HTLV-1 is now available on the PHAC website (). If working with HIV or HTLV-1, it is now your responsibility to comply with this directive in conjunction with the (CBSG) 1st edition.
Recent News
- The Association of Commonwealth Universities (ACU) Funding Opportunities 2024‑25
- Social Sciences and Humanities Research Council
- Global Research Fund
- Genome Canada
- NS‑USA Subsea Cable Socioeconomic Study
- CIHR Institute of Cancer Research
- Webinar in Equity, Diversity and Inclusion (EDI)
- Nova Scotia Office of Addictions and Mental Health